BrainStorm
Subscribe on your favorite player
Listen on Apple Podcasts Listen on Spotify Listen on Stitcher Listen on Google PodcastsRudy Tanzi and the Latest Alzheimer’s Drugs - part 1
![](/sites/default/files/styles/large/public/2021-11/UsA2_BrainStorm%20Podcast_September%2013%202021.jpg?h=7b87a11b&itok=AVmsdf9h)
Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1
Will 2023 be a boom or bust year for new Alzheimer’s drugs?
In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School. Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s.
![](/sites/default/files/styles/large/public/2021-11/UsA2_BrainStorm%20Podcast_September%2013%202021.jpg?h=7b87a11b&itok=AVmsdf9h)
About This Episode
Will 2023 be a boom or bust year for new Alzheimer’s drugs?
In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School. Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s.